[27 November 2012]
Products Affected - Description
Cyclosporine (modified) oral products
Reason for the Shortage
- Sandoz had cyclosporine (modified) capsules on shortage due to manufacturing delays.
- Teva had cyclosporine (modified) capsules on shortage due to increased demand.
- Watson could not provide a reason for the shortage of cyclosporine (modified) capsules.
Available Products
Cyclosporine (modified) oral products, Sandoz
25 mg capsules, 30 count (NDC 00185-0932-30)
100 mg capsules, 30 count (NDC 00185-0933-30)
Cyclosporine (modified) oral products, Teva
25 mg capsules, 30 count (NDC 00172-7310-46)
50 mg capsules, 30 count (NDC 00172-7311-46)
100 mg capsules, 30 count (NDC 00172-7312-46)
100 mg/mL, 50 mL oral solution (NDC 00172-7313-20)
Cyclosporine (modified) oral products, Watson
25 mg capsules, 30 count (NDC 00591-2222-15)
100 mg capsules, 30 count (NDC 00591-2223-15)
100 mg/mL, 50 mL oral solution (NDC 00591-2224-55)
Gengraf (modified) oral products, Abbott
25 mg capsules, 30 count (NDC 00074-6463-32)
100 mg capsules, 30 count (NDC 00074-6479-32)
100 mg/mL, 50 mL oral solution (NDC 00074-7269-50)
Neoral (modified) oral products, Novartis
25 mg capsules, 30 count (NDC 00078-0246-15)
100 mg capsules, 30 count (NDC 00078-0248-15)
100 mg/mL, 50 mL oral solution (NDC 00078-0274-22)
Estimated Resupply Dates
All presentations are currently available.
Related Shortages
Updated
November 27, 2012; October 22, 2012; October 4, 2012; August 3, 2012; June 19, 2012; May 21, 2012; May 2, 2012; April 10, 2012; March 8, 2012, University of Utah, Drug Information Service. Copyright 2012, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins